A carregar...
Rapid Desensitization for Immediate Hypersensitivity to Galsulfase Therapy in Patients with MPS VI
Mucopolysaccharidosis type VI (MPS VI) is a progressive, chronic, and multisystem lysosomal storage disease. Enzyme replacement therapy (ERT) with the recombinant human arylsulfatase B enzyme (galsulfase [Naglazyme]) is recommended as first-line therapy. It is generally reported as safe and well tol...
Na minha lista:
| Publicado no: | JIMD Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5110439/ https://ncbi.nlm.nih.gov/pubmed/26951141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2016_542 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|